|
female |
10 |
|
humans |
10 |
|
male |
10 |
|
middle aged |
10 |
|
carotid intima-media thickness |
8 |
|
case-control studies |
8 |
|
25-hydroxyvitamin d |
7 |
|
aged |
7 |
|
blood flow velocity |
7 |
|
circulating endothelial progenitor cells |
7 |
|
incidence |
7 |
|
isoflavone |
7 |
|
pleiotropic effects |
7 |
|
questionnaires |
7 |
|
statin therapy |
7 |
|
vascular function |
7 |
|
adult |
6 |
|
ankle brachial index |
6 |
|
arterial stiffness |
6 |
|
atrial fibrillation |
6 |
|
atrial fibrillation - complications |
6 |
|
brachial artery - physiopathology |
6 |
|
brain ischemia - epidemiology - etiology |
6 |
|
cardiovascular diseases - blood - diet therapy - prevention & control |
6 |
|
cardiovascular diseases - etiology |
6 |
|
confounding factors (epidemiology) |
6 |
|
cross-sectional studies |
6 |
|
deficiency diseases - complications - physiopathology |
6 |
|
diet records |
6 |
|
dietary supplements |
6 |
|
endothelial cells - cytology - physiology |
6 |
|
endothelial progenitor cells |
6 |
|
endothelium, vascular - cytology - physiology |
6 |
|
energy intake |
6 |
|
flow cytometry |
6 |
|
follow-up studies |
6 |
|
hyperthyroidism |
6 |
|
hyperthyroidism - complications |
6 |
|
ischemic stroke |
6 |
|
nutrition |
6 |
|
nutrition assessment |
6 |
|
phytoestrogen |
6 |
|
phytoestrogens - administration & dosage |
6 |
|
proportional hazards models |
6 |
|
prospective studies |
6 |
|
retrospective studies |
6 |
|
risk |
6 |
|
secondary prevention |
6 |
|
selenium - administration & dosage - deficiency |
6 |
|
selenium deficiency |
6 |
|
stem cells - physiology |
6 |
|
trace elements - deficiency |
6 |
|
vascular diseases - etiology - physiopathology |
6 |
|
antibiotics resistance |
5 |
|
antigens, cd34 - analysis |
5 |
|
arteriosclerosis - etiology - pathology - ultrasonography |
5 |
|
berberine |
5 |
|
brachial artery - drug effects - physiology |
5 |
|
c-reactive protein |
5 |
|
c-reactive protein - metabolism |
5 |
|
carotid arteries - pathology - ultrasonography |
5 |
|
cell count |
5 |
|
community |
5 |
|
education |
5 |
|
endothelial cells - pathology |
5 |
|
endothelial dysfunction |
5 |
|
endothelium, vascular - drug effects |
5 |
|
endothelium, vascular - pathology - ultrastructure |
5 |
|
isoflavones - administration and dosage - therapeutic use |
5 |
|
knowledge |
5 |
|
nonadherence |
5 |
|
randomized controlled trial |
5 |
|
risk factors |
5 |
|
soybean proteins - therapeutic use |
5 |
|
stem cells - pathology |
5 |
|
stroke - pathology |
5 |
|
testosterone |
5 |
|
tunica intima - ultrasonography |
5 |
|
tunica media - ultrasonography |
5 |
|
analysis of variance |
4 |
|
atrial fibrillation - etiology - therapy |
4 |
|
blood pressure - drug effects - physiology |
4 |
|
cardiovascular diseases - epidemiology - metabolism |
4 |
|
diet surveys |
4 |
|
electric countershock |
4 |
|
endothelium, vascular - drug effects - physiology |
4 |
|
flow-mediated dilation |
4 |
|
isoflavones - administration & dosage |
4 |
|
lipid metabolism - drug effects - physiology |
4 |
|
manufacturers |
4 |
|
recurrence |
4 |
|
soybean proteins - administration & dosage |
4 |
|
soybeans - chemistry |
4 |
|
time factors |
4 |
|
treatment outcome |
4 |
|
tunica intima - pathology - ultrasonography |
4 |
|
tunica media - pathology - ultrasonography |
4 |
|
alcohol |
2 |
|
aspirin - administration and dosage |
2 |
|
blood pressure |
2 |
|
cardiovascular diseases - epidemiology |
2 |
|
colorectal neoplasms - diagnosis - epidemiology - prevention and control |
2 |
|
gastrointestinal hemorrhage - chemically induced |
2 |
|
left ventricular hypertrophy |
2 |
|
pathway analysis |
2 |
|
platelet aggregation inhibitors - administration and dosage |
2 |
